Wormser GP et al. Clinical Infectious Diseases 2006;43:1089-1134. Republished with permission from University of Chicago Press. © 2006 by the Infectious Diseases Society of America. All rights reserved.


Table Four: Selected antimicrobials, drug regimens, or other modalities not recommended for the treatment of Lyme disease.

Doses of antimicrobials far in excess of those provided in tables 2 and 3
Multiple, repeated courses of antimicrobials for the same episode of Lyme disease or a duration of antimicrobial therapy prolonged far in excess of that shown in table 3
Combination antimicrobial therapy
Pulsed-dosing (i.e., antibiotic therapy on some days but not on other days)
First-generation cephalosporins, benzathine penicillin G, fluoroquinolones, carbapenems, vancomycin, metronidazole, tinidazole, trimethoprim-sulfamethoxazole, amantadine, ketolides, isoniazid, or fluconazole
Empirical antibabesiosis therapy in the absence of documentation of active babesiosis
Anti-Bartonella therapies
Hyperbaric oxygen therapy
Fever therapy (with or without malaria induction)
Intravenous immunoglobulin
Ozone
Cholestyramine
Intravenous hydrogen peroxide
Vitamins or nutritional managements
Magnesium or bismuth injections